date:May 20, 2013
erational execution of cost reduction initiatives under the Glanbia Performance System.
While high end whey prices remained relatively strong, overall whey market prices for the first four months of the year were behind prior year levels as predicted and this resulted in reduced pricing in Ingredient Technologies. However this was largely offset by volume growth in the period due to increased throughput of WPC34 and lactose together with the impact of Aseptic Solutions, acquired in July 2012. A